These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 28038733)
1. Genetic mutation risk calculation in Lynch syndrome inheritance: Evaluating the utility of the PREMM Aissaoui S; Cartellier C; Seytier T; Giraud S; Calender A Bull Cancer; 2017 Mar; 104(3):288-294. PubMed ID: 28038733 [TBL] [Abstract][Full Text] [Related]
2. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
3. Development and Validation of the PREMM Kastrinos F; Uno H; Ukaegbu C; Alvero C; McFarland A; Yurgelun MB; Kulke MH; Schrag D; Meyerhardt JA; Fuchs CS; Mayer RJ; Ng K; Steyerberg EW; Syngal S J Clin Oncol; 2017 Jul; 35(19):2165-2172. PubMed ID: 28489507 [TBL] [Abstract][Full Text] [Related]
4. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186 [TBL] [Abstract][Full Text] [Related]
5. Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. Lagerstedt Robinson K; Liu T; Vandrovcova J; Halvarsson B; Clendenning M; Frebourg T; Papadopoulos N; Kinzler KW; Vogelstein B; Peltomäki P; Kolodner RD; Nilbert M; Lindblom A J Natl Cancer Inst; 2007 Feb; 99(4):291-9. PubMed ID: 17312306 [TBL] [Abstract][Full Text] [Related]
6. Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy. Najdawi F; Crook A; Maidens J; McEvoy C; Fellowes A; Pickett J; Ho M; Nevell D; McIlroy K; Sheen A; Sioson L; Ahadi M; Turchini J; Clarkson A; Hogg R; Valmadre S; Gard G; Dooley SJ; Scott RJ; Fox SB; Field M; Gill AJ Pathology; 2017 Aug; 49(5):457-464. PubMed ID: 28669579 [TBL] [Abstract][Full Text] [Related]
7. Lynch Syndrome in Thai Endometrial Cancer Patients. Manchana T; Ariyasriwatana C; Triratanachat S; Phowthongkum P Asian Pac J Cancer Prev; 2021 May; 22(5):1477-1483. PubMed ID: 34048176 [TBL] [Abstract][Full Text] [Related]
8. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing]. Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589 [No Abstract] [Full Text] [Related]
10. Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome. Adar T; Rodgers LH; Shannon KM; Yoshida M; Ma T; Mattia A; Lauwers GY; Iafrate AJ; Hartford NM; Oliva E; Chung DC Cancer; 2018 Aug; 124(15):3145-3153. PubMed ID: 29750335 [TBL] [Abstract][Full Text] [Related]
11. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening. Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703 [TBL] [Abstract][Full Text] [Related]
13. Multigene Panel Testing Provides a New Perspective on Lynch Syndrome. Espenschied CR; LaDuca H; Li S; McFarland R; Gau CL; Hampel H J Clin Oncol; 2017 Aug; 35(22):2568-2575. PubMed ID: 28514183 [TBL] [Abstract][Full Text] [Related]
14. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas. Ju JY; Mills AM; Mahadevan MS; Fan J; Culp SH; Thomas MH; Cathro HP Am J Surg Pathol; 2018 Nov; 42(11):1549-1555. PubMed ID: 30148743 [TBL] [Abstract][Full Text] [Related]
15. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge. Ponti G; Manfredini M; Tomasi A; Pellacani G Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115 [TBL] [Abstract][Full Text] [Related]
16. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families. Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C; Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211 [TBL] [Abstract][Full Text] [Related]
17. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience. Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051 [TBL] [Abstract][Full Text] [Related]
18. Gene-Specific Variation in Colorectal Cancer Surveillance Strategies for Lynch Syndrome. Kastrinos F; Ingram MA; Silver ER; Oh A; Laszkowska M; Rustgi AK; Hur C Gastroenterology; 2021 Aug; 161(2):453-462.e15. PubMed ID: 33839100 [TBL] [Abstract][Full Text] [Related]
19. Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Pérez-Carbonell L; Ruiz-Ponte C; Guarinos C; Alenda C; Payá A; Brea A; Egoavil CM; Castillejo A; Barberá VM; Bessa X; Xicola RM; Rodríguez-Soler M; Sánchez-Fortún C; Acame N; Castellví-Bel S; Piñol V; Balaguer F; Bujanda L; De-Castro ML; Llor X; Andreu M; Carracedo A; Soto JL; Castells A; Jover R Gut; 2012 Jun; 61(6):865-72. PubMed ID: 21868491 [TBL] [Abstract][Full Text] [Related]